Mechanisms of Action Flashcards
5α-reductase inhibitors
finasteride
5α-reductase reduces testosterone to active metabolite dihydrotestosterone
Dihydrotestosterone stimulates prostatic growth
So 5α-reductase inhibitors reduce size of prostate gland by inhibiting this
α-blockers
doxazosin, tamsulosin, alfuzosin
Drugs in this class are highly selective for α1-adrenoreceptors
α1-adrenoreceptors are found in smooth muscle e.g. vessels + urinary tract
Stimulation of receptors induces constriction
Blockade of receptors induces relaxation
α1-blockers therefore cause vasodilation, ↓ BP and reduced resistance to bladder outflow
Acetylcholinesterase inhibitors
donepezil, rivastigmine
Acetylcholine is important CNS neurotransmitter (learning + memory)
These drugs inhibit cholinesterase enzymes which break down acetylcholine in CNS
By increasing availability of acetylcholine, these drugs improve cognitive function + slow rate of decline
Acetylcysteine (N-acetylcysteine)
Paracetamol is normally metabolised by conjugation with glucuronic acid and sulfate
Small amount of NAPQI is produced (hepatotoxic) - quickly detoxified by conjugation with glutathione
In poisoning, body’s glutathione is overwhelmed, NAPQI is left free to cause liver damage
Acetylcysteine replenishes body’s supply of glutathione
Activated charcoal
Van der Waals forces
Molecules are aDsorbed onto surface of charcoal as they travel through gut, reducing their aBsorption into circulation
Weakly ionic, hydrophobic substances adsorbed best (e.g. benzodiazepines, methotrexate)
Can also increase elimination of certain poisons - multiple doses used to maintain steep conc. gradient of poison to encourage diffusion out of circulation
Adenosine
Agonist of adenosine receptors on cell surfaces
In heart, activation of these receptors induces several effects:
- Reducing frequency of spontaneous depolarisation
- Increasing resistance to depolarisation
This transiently slows sinus rate and conduction velocity
Increasing AV node refractoriness
Increased refractoriness in AV node breaks the re-entry circuit, which allows normal depolarisations from SA node to resume control of heart rate (cardioversion)
Adrenaline
epinephrine
Potent agonist of α1, α2, β1, β2
α1: vasoconstriction of skin and mucosa vessels
β1: increased heart rate and contractility and excitability
β2: vasodilation of coronary vessels and bronchodilation plus suppression of inflammation mediator release from mast cells
Aldosterone antagonists
spironolactone, eplerenone
Mineralocorticoid
Acts on mineralocorticoid receptors in distal tubules of kidney - increases activity of luminal epithelial Na channels (ENaC)
This increases reabsorption of Na and water, elevates BP, increases secretion of K
Aldosterone antagonists competitively bind causing Na and water EXCRETION and K RETENTION
Alginates and antacids
gaviscon, peptac
Antacids: buffer stomach acids
Alginates: Increase viscosity of stomach contents to reduce reflux - form “floating raft” separating gastric contents from gastro-oesophageal junction
Allopurinol
Xanthine oxidase inhibitor
Xanthine oxidase is enzyme which metabolises xanthine from purines → uric acid
So drug lowers plasma uric acid
Aminoglycosides
gentamicin, amikacin, neomycin
Work mainly on Gram -ve aerobic bacteria
Inhibit 30S ribosome subunit irreversibly
Enter bacteria through oxygen dependent transport system
Penicillins weaken cell wall and so may enhance aminoglycoside activity by increasing bacterial uptake
Aminosalicylates
mesalazine, sulfasalazine
Ulcerative Colitis:
Release 5-ASA which seems to have anti-inflammatory and immunosuppressive effects
Act topically on gut rather than systemically so preparations delay release of active ingredient until reaching colon
Rheumatoid Arthritis:
Sulfapyridine is probably active component, mechanism unclear
Amiodarone
Blockade of Na, Ca, K channels
Antagonism of α- and β-adrenergic receptors
Reduces spontaneous depolarisation, slows conduction velocity and increases resistance to depolarisation, including in AV node
Reduces ventricular rate in AF and atrial flutter (by interfering with AV node)
May break re-entry circuit and restore sinus rhythm in SVT
Options for treatment and prevention in VT
Improves chances of successful defibrillation in refractory VF
ACE inhibitors
ramipril, lisinopril, perindopril
Block ACE to prevent conversion of angiotensin I to angiotensin II
Angiotensin II is a vasoconstrictor + stimulates aldosterone secretion
Inhibition therefore causes ↓ BP
Dilates efferent glomerular arteriole so slows progression of CKD
Reducing aldosterone level promotes Na and water excretion so reduces preload
Angiotensin receptor blockers
losartan, candesartan, irbesartan
Block action of angiotensin II on angiotensin type 1 receptor
Angiotensin II = vasoconstrictor, stimulates aldosterone secretion, constricts efferent arteriole
ARBs = opposite effect
Antidepressants
tricyclics; amitriptyline, lofepramine
Inhibit reuptake of noradrenaline and 5-HT from synaptic cleft, thereby increasing their availability for neurotransmission
Block a wide array of receptors (muscarinic, histamine, α-adrenergic and dopamine) therefore have extensive side effects
Antidepressants
venfalaxine, mirtazapine
Venlafaxine = SNRI Mirtazapine = antagonist of pre-synaptic α2-adrenoreceptors
Both drugs increase availability of monoamines for neurotransmission
Venlafaxine is weaker antagonist of muscarinic and histamine receptors than tricyclics
Mirtazapine is portent agonist of histamine (NOT muscarinic) receptors so commonly causes sedation
Antiemetics - dopamine D2-receptor antagonists
metoclopramide, domperidone
Nausea + vomiting triggered by a wide arrange of stimuli that all converge in “vomiting centre” in medulla (this receives input form chemoreceptor trigger zone, solitary tract nucleus, vestibular system and higher centres)
D2 receptor is main receptor in chemoreceptor trigger zone (CTZ) which senses emetogenic substances in blood - therefore D2RAs are good for nausea caused by CTZ stimulation (e.g. drugs)
D2 is important in gut where it promotes relaxation of stomach and LOS , and inhibits gastroduodenal coordination - therefore D2RAs have prokinetic effect → gastric emptying which contributes to antiemetic action in conditions with reduced gut motility (e.g. due to opioids)
Antiemetics - histamine H1-receptor antagonists
cyclizine, cinanrizine, promethazine
Nausea + vomiting triggered by a wide arrange of stimuli that all converge in “vomiting centre” in medulla (this receives input form chemoreceptor trigger zone, solitary tract nucleus, vestibular system and higher centres)
Histamine and acetylcholine (muscarinic) receptors predominate in the vomiting centre and its communication with the vestibular system
H1RAs block both receptors and are therefore useful in a wide range of conditions, particularly when associated with motion/vertigo
Antiemetics - serotonin 5-HT3-receptor antagonists
ondansetron, granisetron
Nausea + vomiting triggered by a wide arrange of stimuli that all converge in “vomiting centre” in medulla (this receives input form chemoreceptor trigger zone, solitary tract nucleus, vestibular system and higher centres)
High concentration of 5-HT3 receptors in the CTZ responsible for sensing emetogenic substances in the blood (e.g. drugs)
5-HT is key neurotransmitter released by gut in response to emetogenic stimuli
It stimulates the vagus nerve, which in turn stimulates vomiting centre via solitary tract nucleus
Effective against N+V as a result of CTZ stimulation (drugs) and visceral stimuli (gut infection, radiotherapy) but NIOT motion sickness
Antifungal drugs
nystatin, clotrimazole, fluconazole
Fungal cell membranes contain ergosterol, human cells do not, therefore it is a target for antifungals
Polyene antifungals (nystatin) bind to ergosterol in cell membrane, creating polar pore which allows intracellular ions to leak out, killing/slowing growth of fungi
Imidazole (clotrimazole) and triazole (fluconazole) fungals inhibit ergosterol synthesis, impairing cell membrane synthesis and cell growth + replication
Antihistamines - H1-receptor antagonists)
cetirizine, loratadine, fexofenadine, chlorpgenamine
Antagonism of H1 receptor, which blocks the effects of excess histamine:
Increased capillary permeability causing oedema
Vasodilation causing erythema
Nasal irritation
Sneezing
Rhinorrhoea
Congestion
Conjunctivitis
Itch
Urticaris
Antimotility drugs
loperamide, codeine phosphate
Loperamide is an ggonist of opioid receptors in gut
Increases non-propulsive contractions of gut smooth muscle, but reduces propulsive (peristaltic) contractions
Transit of bowel contents is slowed and anal sphincter tone is increased
Antimuscarinics - bronchodilators
ipratropium, tiotropoium, glycopyrronium, aclidinium
Bind to muscarinic receptor and competitively inhibit acetylcholine
Stimulation of muscarinic receptor brings about parasympathetic/”rest and digest” effects
In blocking the receptor, antimuscarinics have the opposite effects:
Increase HR and conduction
Reduce smooth muscle tone (inc. resp tract and bladder)
Reduce secretions from gland in resp and GI tracts
Relaxation of pupillary constrictor + ciliary muscles in eye
Antimuscarinics - cardiovascular and GI uses
atropine, hyoscine butylbromide, glycopyrronium
Bind to muscarinic receptor and competitively inhibit acetylcholine
Stimulation of muscarinic receptor brings about parasympathetic/”rest and digest” effects
In blocking the receptor, antimuscarinics have the opposite effects:
Increase HR and conduction
Reduce smooth muscle tone and peristaltic contraction (including GU tract)
Reduce secretions from resp tract and gut
Relaxation of pupillary and ciliary muscles in eye
Antimuscarinics - GU uses
oxybutynin, tolterodine, solifenacin
Bind to muscarinic receptor and competitively inhibit acetylcholine
Promotes bladder relaxation
Reduces urinary frequency, urgency and urge incontinence
Through antagonism of the M3 receptor
Antipsychotics - 1st generation (typical)
haloperidol, chlorpromazine, prochlorperazine
Block post-synaptic dopamine D2 receptors
Incompletely understood mechanism
Antipsychotics - 2nd generation (atypical)
quetiapine, olanzapine, risperidone, clozapine
Block post-synaptic dopamine D2 receptors
Incompletely understood mechanism
Antiviral drugs
aciclovir
HSV1 & 2 contain double-stranded DNA
This requires herpes-specific DNA polymerase for the virus to replicate
Aciclovir enters herpes-infected cells and inhibits the herpes-specific DNA polymerase
Inhibiting further viral DNA synthesis & replication
Antiplatelet drugs - ADP-receptor antagonists
clopidogrel, ticagrelor, prasugrel
Prevent platelet aggregation
Bind irreversibly to adenosine diphosphate (ADP) receptors on surface of platelets
Antiplatelet drugs
aspirin
Irreversibly inhibits COX to reduce production of pro-aggregatory factor thromboxane form arachidonic acid
Reducing platelet aggregation
Azathioprine
Pro-drug
Main metabolite is 6-mercaptopurine
Metabolites inhibit synthesis of purines and therefore inhibit DNA and RNA replication
β-blockers
bisoprolol, atenolol, propanolol, metoprolol, carvedilol
Reduce force of contraction and speed of conduction in the heart
Relieves myocardial ischaemia by reducing cardiac work and oxygen demand
Slow ventricular rate in AF by prolonging refractory period of the AV node
Reduce hypertension through variety of mechanisms including reducing renin secretion from kidneys
β2-agonists
salbutamol, terbutaline, salmeterol, formoterol, indacaterol
B2 receptors found in smooth muscle of gut, bronchi, uterus and vessels
Stimulation leads to smooth muscle activation
Improves airflow in constricted airways
Stimulates Na/K/ATPase pumps, causing shift of K from extracellular to intercellular compartment
Useful adjunct in hyperkalaemia
Benzodiazepines
diazepam, temazepam, lorazepam, chlordiazepoxide, midazolam
Target is the GABAa receptor - a chloride channel that opens in response to binding by GABA
Opening channel allows chloride to flood in, making the cell more resistant to depolarisation
Benzos facilitate and enhance binding of GABA to GABAa receptor
Wide depressant effect - reduced anxiety, sleepiness, sedation, anticonvulsion
Bisphosphonates
alendronic acid, disodium pamidronate, zoledronic acid
Reduce bone turnover by inhibiting action of osteoclasts (cells responsible for resorption)
Bisphosphonates accumulate in osteoclasts where they inhibit activity and promote apoptosis
Reduction in bone loss and improved bone mass
Calcium and vitamin D
calcium carbonate, calcium gluconate, colecalciferol, alfacalcidol
Calcium homeostasis is controlled by parathyroid hormone and vitamin D (which increase serum calcium and bone mineralisation) and calcitonin (which reduces serum calcium)
In osteoporosis, calcium + vit D may reduce rate of bone loss
In CKD there is hyperphosphataemia and hypocalcaemia
In hyperkalaemia, calcium raises myocardial threshold potential, reducing excitability and risk of arrhythmias
Calcium channel blockers
amlodipine, nifedipine, dilitiazem, verapamil
Decrease calcium entry into vascular and cardiac cells, reducing intracellular calcium concentration
Causing relaxation and vasodilation in arterial smooth muscle
In heart, CCBs reduce myocardial contractility
Suppress cardiac conduction, slowing ventricular rate
Reduced cardiac rate, contractility and afterload reduce myocardial oxygen demand, preventing angina